Work

Safety, tolerability and efficacy of the use of tixagevimab/cilgavimab as pre‐exposure COVID‐19 prophylaxis in kidney and simultaneous pancreas kidney transplant recipients

Year: 2025

Type: article

Study design: Observational Study

Source: Internal Medicine Journal

DOI: 10.1111/imj.70179

Authors: Wai H Lim, Jiayue Wang, Helen Pilmore, Stella McGinn, Anoushka Krishnan, Armando Teixeira‐Pinto, Anh Kieu, Owen Ng, Germaine Wong

Institutions: Edith Cowan University, The University of Western Australia, Sir Charles Gairdner Hospital, The University of Sydney, University of Auckland, Auckland City Hospital, Royal North Shore Hospital, Royal Perth Hospital, Children's Hospital at Westmead, Westmead Hospital

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: AstraZeneca Australia

OpenAlex ID: W4414570080

FWCI:

Cites: 15

Cited by:

Related to: